H.R. 8190 · 116th Congress

Biosimilar Insulin Access Act of 2020

Stage
In committee
Introduced
2020-09-08
Latest action
2020-09-16 · Sponsor introductory remarks on measure.

Subjects

Health
Licensing and registrations
Drug therapy
Health technology, devices, supplies
Intellectual property
Prescription drugs
Blood and blood diseases
Competition and antitrust
Drug safety, medical device, and laboratory regulation